18 Mar 2015 07:00
Deltex Medical Group plc("Deltex Medical" or "the Company")
Director/PDMR Shareholding
Â
18 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that two Directors purchased shares in the Company.
Â
Tim Irish, non-executive Director, notified the Company on 17 March 2015 of the purchase of 1,000,000 Ordinary Shares at a price of 6.475 pence per Ordinary Share. As a result Mr Irish's shareholding totals 2,848,484 ordinary shares (representing 1.34 per cent. of the issued share capital of Deltex Medical).
Â
Paul Mitchell, Finance Director, notified the Company on 17 March 2015 of the purchase of 145,019 Ordinary Shares at an average price of 6.86 pence per Ordinary Share. As a result Mr Mitchell's shareholding totals 654,831 ordinary shares (representing 0.31 per cent. of the issued share capital of Deltex Medical).
Â
For further information, please contact:-
Â
Deltex Medical Group plc | 01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman | |
Ewan Phillips, Chief Executive | |
Paul Mitchell, Finance Director | |
Barry Curtis, Company Secretary | |
Nominated Adviser & Broker | |
Arden Partners plc | 020 7614 5900 |
Chris Hardie | |
 Joint Broker Zeus Capital Limited Dominic Wilson John Goold  |   020 7533 7727  |
Financial Public Relations | |
Newgate | 020 7653 9850 |
Tim Thompson | |
Robyn McConnachie Ed Treadwell |
Â
Â